Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Krystal Biotech Inc (NQ: KRYS)
20.00 USD  +3.86 (+23.92%)
Official Closing Price  /  Updated: 4:13 PM EDT, Oct 15, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 585,054
Open 20.33
Bid (Size) 19.56 (10)
Ask (Size) 21.65 (5)
Prev. Close 16.14
Today's Range 18.00 - 21.89
52wk Range 8.030 - 21.17
Shares Outstanding 10,309,615
Dividend Yield N/A
Performance
YTD
+117.86%
+117.86%
1 Month
+19.98%
+19.98%
3 Month
+14.29%
+14.29%
6 Month
+100.00%
+100.00%
1 Year
+109.21%
+109.21%
Top News
More News
This Biotech Has A Topical Gene Therapy — And Just Flew 30% On A Test
Krystal Biotech rocketed to a record high Monday — outperforming a slide for biotech companies — after its gene therapy showed promise as a skin disease treatment. Read More
from Investor's Business Daily
Krystal Biotech Announces Positive Interim Results from Placebo-Controlled Phase 1/2 Clinical Trial of KB103
Krystal Biotech, Inc. (Nasdaq:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today announced positive... Read More
from GlobeNewswire News Releases
More News
Read More
Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
from GlobeNewswire News Releases
Krystal Biotech to Present at 2018 Cell & Gene Meeting on the Mesa
from GlobeNewswire News Releases
Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalmann Conferences
from GlobeNewswire News Releases
Krystal Biotech to Present at Upcoming B. Riley FBR and H.C. Wainwright Healthcare Investor Conferences
from GlobeNewswire News Releases
Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
from GlobeNewswire News Releases
Chardan Capital Markets acts as Sole Placement Agent in $10 Million Securities Purchase
from PR Newswire
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Sears Holdings Shares Plummet
category RLGY , ABCD , Benzinga , and 17 more.
from Benzinga
Krystal Biotech Announces $10 Million Private Placement with Frazier Healthcare Partners
from GlobeNewswire News Releases
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.